Thromboembolic Risk in Nonanticoagulated Patients With Atrial Fibrillation and Valvular Heart Disease
Authors:
- 1 December 2020
- journal article
- research article
- Published by Elsevier in JACC: Clinical Electrophysiology
- Vol. 6 (13) , 1672-1682
Abstract
No abstract availableKeywords
Funding Information
- Takeda Pharmaceutical Company
- Roche
- Janssen Pharmaceutica
- Medtronic
- Daiichi-Sankyo
- Bristol-Myers Squibb
- Biotronik
- Pfizer
- Det Obelske Familiefond
- Boehringer Ingelheim
This publication has 38 references indexed in Scilit:
- Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort studyJournal of Thrombosis and Haemostasis, 2012
- Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registryScandinavian Cardiovascular Journal, 2012
- The Danish National Patient RegisterScandinavian Journal of Public Health, 2011
- The Danish Civil Registration SystemScandinavian Journal of Public Health, 2011
- The Danish National Prescription RegistryScandinavian Journal of Public Health, 2011
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Moving the Tipping PointCirculation: Cardiovascular Quality and Outcomes, 2011
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Validity of Stroke Diagnoses in a National Register of PatientsNeuroepidemiology, 2007
- Prevalence and predictors of atrial fibrillation in rheumatic valvular heart diseaseThe American Journal of Cardiology, 1996